Old Web
English
Sign In
Acemap
>
authorDetail
>
Markus Zabransky
Markus Zabransky
Medicine
Pediatrics
Endocrinology
Internal medicine
Physical therapy
7
Papers
79
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
2017
Drug Design Development and Therapy
Martin Schiestl
Markus Zabransky
Fritz Sörgel
Show All
Source
Cite
Save
Citations (38)
Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patients.
2016
Medical Devices : Evidence and Research
Dirk Schnabel
Carl Joachim Partsch
Muriel Houang
Sarah Ehtisham
Helen Johnstone
Markus Zabransky
Wieland Kiess
Show All
Source
Cite
Save
Citations (1)
Acceptability of the reusable SurePal™ self-injection device for Omnitrope ® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study
2015
Medical Devices : Evidence and Research
Carl Joachim Partsch
Dirk Schnabel
Sarah Ehtisham
Helen Johnstone
Markus Zabransky
Wieland Kiess
Show All
Source
Cite
Save
Citations (4)
Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow‐on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis
2010
The Journal of Clinical Pharmacology
Richard Stanhope
Fritz Sörgel
Patricia Gravel
Yannic B. Pannatier Schuetz
Markus Zabransky
Michael Muenzberg
Show All
Source
Cite
Save
Citations (21)
1